Evidence map›Paper›PMID 40535631›Full record

ArticleAmerican journal of translational research2025

Feasibility and efficacy of remimazolam for anesthesia monitoring in transcatheter aortic valve implantation via femoral artery access.

Xin Liang, Xin Deng, Qiying Lao, Longqian Chen, Yanli Liang, Liu Yang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xin LiangDepartment of Anesthesiology, Central People's Hospital of Zhanjiang Zhanjiang 524031, Guangdong, China.
Xin DengGuangdong Medical University Dongguan 523808, Guangdong, China.
Qiying LaoDepartment of Anesthesiology, Central People's Hospital of Zhanjiang Zhanjiang 524031, Guangdong, China.
Longqian ChenDepartment of Anesthesiology, Central People's Hospital of Zhanjiang Zhanjiang 524031, Guangdong, China.
Yanli LiangDepartment of Anesthesiology, Central People's Hospital of Zhanjiang Zhanjiang 524031, Guangdong, China.
Liu YangDepartment of Anesthesiology, Central People's Hospital of Zhanjiang Zhanjiang 524031, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the effect of remimazolam during anesthesia monitoring in transcatheter aortic valve implantation (TAVI) via femoral artery catheter (FAC).

methodsWe reviewed the medical records of 50 patients who underwent TAVI via FAC from July 2022 to September 2023. Patients were divided into two groups: a control group (receiving propofol, n=25) and a remimazolam group (receiving remimazolam, n=25). Pulse oxygen saturation (SpO

resultsAt T2, T3, T4 and T5, the remimazolam group exhibited significantly higher SpO

conclusionRemimazolam is an effective sedative for TAVI anesthesia, associated with lower postoperative adverse reactions, thus facilitating better recovery.

Indexed as

anesthesia monitoringpostoperative deliriumRemimazolamtranscatheter aortic valve implantation via femoral artery catheter

Identifiers

PMID40535631
PMCPMC12170432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.